Home Pharmacy Comprehensive System Addition 2: 100 Points, Billable for Critically Ill Patients Including Facility Residents – Nikkei Medical

SUMMARY

Google News: According to reports on the medical fee revision, Nikkei Medical has announced that "Home Pharmacy Comprehensive System Addition 2: 100 Points, Billable for Critically Ill Patients Including Facility Residents" is being reported. This is information that can be used for management decisions by hospitals, clinics, and medical corporations as the latest trend in the medical industry.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Trends in the medical industry directly impact the succession and M&A strategies of hospitals, clinics, and medical corporations. Changes in the complex management environment, such as revisions to medical fees, lack of successors, staffing shortages, burden of capital investment, and progress in regional medical plans, are forcing medical institutions to make new management decisions.

As an option for successor issues and changes in the management environment,Third-Party Succession M&Ais increasing in importance year by year. Choosing succession over closure or廃業 (business dissolution) allows for the simultaneous achievement of securing a transfer price, maintaining staff employment, ensuring continuity of patient care, and preserving regional medical services. The framework of M&A support institutions certified by the Small and Medium Enterprise Agency has also been established, and advisory services specializing in the unique licensing, tax, and labor issues of the medical industry have become widespread.

For medical institutions, accurately grasping industry trends and seeking early consultation with experts are key to attracting the best options for management decisions. As an M&A advisory firm specializing in the medical industry, we support medical institutions with free consultations and success-fee-based services.

News Highlights

On May 30, 2026, Nikkei Medical reported that the billing requirements for "Home Pharmacy Comprehensive System Addition 2" have been changed, making it billable at 100 points even for critically ill patients, including those residing in facilities. This change may contribute to the expansion of pharmacy roles and improvement of profitability in home healthcare.

M&A Medical Editorial Department's Perspective

今回の「在宅薬学総合体制加算2」における施設入居者を含む重症患者への100点算定拡大は、在宅医療に注力する薬局にとって、収益構造を強化する絶好の機会と言えます。特に、これまで算定が難しかったケースでの点数化は、在宅医療への投資を回収し、さらなるサービス拡充を可能にします。これは、M&Aの観点からも、在宅医療に強みを持つ薬局の事業価値を高める要因となり得ます。買収側は、この加算による収益増加を見込み、より高い評価額を提示する可能性があります。逆に、この加算を最大限に活用できる体制を構築できていない薬局は、相対的に競争力が低下するリスクも考えられます。事業承継を検討する経営者は、この加算を自社の収益にどう組み込めるか、また、M&Aを通じてこの機会を活かせるか、戦略的に検討すべきでしょう。

Points Raised by This News

Potential for Increased Profitability and Service Expansion for Pharmacies in Home Healthcare
Strengthening Support for Facility Residents and Critically Ill Patients Directly Leads to Increased Business Value for Pharmacies
Could Become a Factor in the Increased Valuation of Home Healthcare-Specialized Pharmacies in the M&A Market
Whether Billing Requirement Changes Can Be Leveraged for Strengthening Revenue Structure Will Determine Competitiveness Among Pharmacies

Practical Questions Arising from This News

What is the specific expected increase in revenue due to this addition change?
What specific system preparations should pharmacies take to strengthen home healthcare for facility residents?
When considering M&A, how should the revenue increase from this addition be incorporated into the valuation?

If You Feel "Should I Consult Too?"

Consult with experts to determine if your pharmacy is structured to maximize the "Home Pharmacy Comprehensive System Addition 2" billing requirement changes, and if this opportunity can be leveraged for business succession or expansion through M&A. In particular, if you are considering strengthening home healthcare for facility residents or planning M&A with the expectation of increased revenue from this addition, we can provide support for developing specific strategies.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation

📌 Source (Primary Information)

Home Pharmacy Comprehensive Support System Fee 2 (100 points) now claimable for severely ill patients, including facility residents – Nikkei Medical

Source: Google News: Medical Fee Revision

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →